SS
SPPI

Steve Schonfeld’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Steve Schonfeld’s Portfolio SPPI Stock Details SPPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-14,800
Closed -$249K – 1274
2018
Q3 		$249K Sell
14,800
-4,200
-22% -$90.9K 0.01% 724
2018
Q2 		$399K Sell
19,000
-16,461
-46% -$305K 0.02% 578
2018
Q1 		$571K Buy
35,461
+12,757
+56% +$253K 0.04% 442
2017
Q4 		$430K Buy
+22,704
New +$411K 0.04% 497

Other funds holding SPPI

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Steve Schonfeld's SPPI Position: Q4 2018 in Review

Steve Schonfeld sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q4 2018, closing a stake of 14,800 shares — an estimated $249K sold.

Steve Schonfeld first reported a position in SPPI in Q4 2017 and held it in 4 quarters. The position peaked at $571K in Q1 2018. 176 funds tracked by Wall St. Rank hold SPPI as of Q4 2018.

  • Steve Schonfeld reported no remaining Spectrum Pharmaceuticals Inc position as of Q4 2018 after selling out during the quarter.
  • Steve Schonfeld sold 14,800 Spectrum Pharmaceuticals Inc shares in Q4 2018, an estimated $249K.
  • Steve Schonfeld first reported a position in Spectrum Pharmaceuticals Inc in Q4 2017 and held it in 4 quarters.
  • Steve Schonfeld's Spectrum Pharmaceuticals Inc position peaked at $571K in Q1 2018.
  • 176 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q4 2018.

Based on Schonfeld Strategic Advisors's 13F filing for Q4 2018, filed 14 Feb 2019.